PANPHARMA Trademark

Trademark Overview


On Monday, May 19, 2014, a trademark application was filed for PANPHARMA with the United States Patent and Trademark Office. The USPTO has given the PANPHARMA trademark a serial number of 79151519. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 4, 2022. This trademark is owned by PANPHARMA, Société anonyme. The PANPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, f...
panpharma

General Information


Serial Number79151519
Word MarkPANPHARMA
Filing DateMonday, May 19, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 4, 2022
Registration Number4774728
Registration DateTuesday, July 21, 2015
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 5, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; pharmaceutical preparations for smoking cessation, pharmaceutical sedatives, tranquilizers, depuratives for the body; vitamin, mineral supplements and vaccines for use on domestic animals and livestock for veterinary purposes; dietetic foods, namely, crackers, cakes, soup, meal replacement bars, fruit and vegetable granules adapted for medical use; pesticides, namely, preparations for destroying vermin within the province of the pharmaceutical sector
Pseudo MarkPAN PHARMA
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePANPHARMA, Société anonyme
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressF-35133 LUITRE
FR

Party NamePANPHARMA, Société anonyme
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-35133 LUITRE
FR

Party NamePANPHARMA, Société anonyme
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-35133 LUITRE
FR

Trademark Events


Event DateEvent Description
Friday, November 17, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 13, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, October 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, October 14, 2022INVALIDATION PROCESSED
Tuesday, October 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 4, 2022CANCELLED SECTION 71
Thursday, December 2, 2021INTERNATIONAL REGISTRATION RENEWED
Saturday, February 27, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 21, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 10, 2015GENERIC MADRID TRANSACTION SENT TO IB
Thursday, December 10, 2015GENERIC MADRID TRANSACTION CREATED
Wednesday, October 21, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 21, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 5, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2015PUBLISHED FOR OPPOSITION
Saturday, May 2, 2015NOTIFICATION PROCESSED BY IB
Wednesday, April 15, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 15, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 28, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 23, 2015ASSIGNED TO LIE
Wednesday, March 4, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 3, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 25, 2014REFUSAL PROCESSED BY IB
Saturday, September 6, 2014APPLICATION FILING RECEIPT MAILED
Friday, September 5, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 5, 2014REFUSAL PROCESSED BY MPU
Friday, September 5, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 4, 2014NON-FINAL ACTION WRITTEN
Wednesday, September 3, 2014ASSIGNED TO EXAMINER
Tuesday, September 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 28, 2014SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB